...
首页> 外文期刊>Clinics >Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial
【24h】

Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial

机译:mar153微粒羟基磷灰石放射滑膜切除术在类风湿关节炎膝关节滑膜炎中的疗效:一项随机对照双盲试验

获取原文

摘要

OBJECTIVES: The aim of the present study was to investigate the effectiveness of Samarium153-particulate hydroxyapatite radiation synovectomy in rheumatoid arthritis patients with chronic knee synovitis. METHODS: Fifty-eight rheumatoid arthritis patients (60 knees) with chronic knee synovitis participated in a controlled double-blinded trial. Patients were randomized to receive either an intra-articular injection with 40 mg triamcinolone hexacetonide alone (TH group) or 40 mg triamcinolone hexacetonide combined with 15 mCi Samarium153-particulate hydroxyapatite (Sm/TH group). Blinded examination at baseline (T0) and at 1 (T1), 4 (T4), 12 (T12), 32 (T32), and 48 (T48) weeks post-intervention were performed on all patients and included a visual analog scale for joint pain and swelling as well as data on morning stiffness, flexion, extension, knee circumference, Likert scale of improvement, percentage of improvement, SF-36 generic quality of life questionnaire, Stanford Health Assessment Questionnaire (HAQ), Lequesne index, use of non-steroidal anti-inflammatory drugs or oral corticosteroids, events and adverse effects, calls to the physician, and hospital visits. RESULTS: The sample was homogeneous at baseline, and there were no withdrawals. Improvement was observed in both groups in relation to T0, but no statistically significant differences between groups were observed regarding all variables at the time points studied. The Sm/TH group exhibited more adverse effects at T1 (p
机译:目的:本研究旨在探讨to153颗粒羟基磷灰石放射滑膜切除术在类风湿关节炎慢性膝关节滑膜炎患者中的有效性。方法:58例风湿性关节炎患者(60膝)患有慢性膝关节滑膜炎,参加了一项对照双盲试验。患者随机接受关节腔内注射单独40 mg曲安奈德(TH组)或40 mg曲安奈德与15 mCi Samarium153颗粒羟基磷灰石(Sm / TH组)联合注射。对所有患者在干预后的基线(T0)和1(T1),4(T4),12(T12),32(T32)和48(T48)周进行盲检查。关节疼痛和肿胀以及早晨僵硬,屈曲,伸展,膝盖围,李克特改善量表,改善百分比,SF-36普通生活质量问卷,斯坦福健康评估问卷(HAQ),Lequesne指数,非甾体类抗炎药或口服皮质类固醇,事件和不良反应,致电医生以及就医。结果:样品在基线时是均质的,没有撤出。两组均相对于T0有所改善,但在研究的时间点上,所有变量之间均未观察到统计学上的显着差异。 Sm / TH组在T1时表现出更多的不良反应(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号